Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 750
Single User License Price INR 53610
Corporate User License Price USD 2250
Corporate User License Price INR 160830
Site License Price USD 1500
Site License Price INR 107220
Request a Quote

Report Title

Intersect ENT Inc. (XENT)-Product Pipeline Analysis, 2016 Update

Quote Request for License Type
License Type Price  
Single User License USD 750
Site License USD 1500
Enterprise Wide License USD 2250
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Intersect ENT Inc. (XENT)-Product Pipeline Analysis, 2016 Update


Quote Request for License Type
License Type Price  
Single User License USD 750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Intersect ENT Inc. (XENT)-Product Pipeline Analysis, 2016 Update

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Intersect ENT Inc. (XENT)-Product Pipeline Analysis, 2016 Update



Executive Summary

Intersect ENT Inc. (Intersect), formerly Sinexus, Inc. is a medical equipment company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. Its products are used in chronic sinusitis treatment such as facial pain or pressure, nasal congestion or obstruction, loss of smell or taste, headache, discolored nasal discharge, loss of sleep or fatigue and depression. Intersect provides treatment through medical therapy and sinus surgery. Intersect has developed the propel steroid-releasing implant. The company distributes its products in domestic and overseas markets. Intersect is headquartered in Menlo Park, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Intersect ENT Inc.

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Intersect ENT Inc. Company Snapshot 6

Intersect ENT Inc. Company Overview 6

Intersect ENT Inc. Pipeline Products and Clinical Trials Overview 7

Intersect ENT Inc.-Pipeline Analysis Overview 9

Key Facts 9

Intersect ENT Inc.-Major Products and Services 10

Intersect ENT Inc. Pipeline Products by Development Stage 11

Intersect ENT Inc. Clinical Trials by Trial Status 13

Intersect ENT Inc. Pipeline Products Overview 14

NOVA-Frontal Indication 14

NOVA-Frontal Indication Product Overview 14

NOVA-Frontal Indication Clinical Trial 15

NOVA- Maxillary Indication 16

NOVA- Maxillary Indication Product Overview 16

Propel Implant-Frontal Indication 17

Propel Implant-Frontal Indication Product Overview 17

Resolve- Ethmoid Sinus 18

Resolve- Ethmoid Sinus Product Overview 18

Steroid-Releasing S8 Sinus Implant 19

Steroid-Releasing S8 Sinus Implant Product Overview 19

Steroid-Releasing S8 Sinus Implant Clinical Trial 20

Intersect ENT Inc.-Key Competitors 21

Intersect ENT Inc.-Key Employees 22

Intersect ENT Inc.-Locations And Subsidiaries 23

Head Office 23

Recent Developments 24

Intersect ENT Inc., Recent Developments 24

Jun 01, 2016: Intersect ENT Announces Completion of Enrollment in RESOLVE II Clinical Trial of New In-Office Implant for Recurrent Chronic Sinusitis 24

May 16, 2016: Intersect ENT Announces Positive Clinical Results From Pivotal Study of Newest Steroid Releasing Sinus Implant 24

May 05, 2016: Intersect ENT Reports First Quarter 2016 Results 25

Mar 23, 2016: Intersect ENT Announces FDA Approval Of Additional Indication For PROPEL Mini Sinus Implant 26

Feb 23, 2016: Intersect ENT Reports Fourth Quarter and Year 2015 Results 27

Feb 22, 2016: Intersect ENT Appoints David Lehman General Counsel 28

Jan 29, 2016: Intersect ENT Announces NUB Status 1 Designation for PROPEL Sinus Implant in Germany 28

Jan 11, 2016: Intersect ENT Reports Preliminary Q4 and Year 2015 Revenue 28

Nov 10, 2015: Intersect ENT Announces Data Further Demonstrating Health Economic Value of PROPEL Steroid Releasing Implants 29

Nov 04, 2015: Intersect ENT Reports Third Quarter 2015 Results 29

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Intersect ENT Inc. Pipeline Products by Equipment Type 8

Intersect ENT Inc. Pipeline Products by Development Stage 11

Intersect ENT Inc. Clinical Trials by Trial Status 13

List of Tables

Intersect ENT Inc. Pipeline Products and Clinical Trials Overview 7

Intersect ENT Inc. Pipeline Products by Equipment Type 7

Intersect ENT Inc. Pipeline Products by Indication 8

Intersect ENT Inc. Clinical Trials by Trial Status 8

Intersect ENT Inc., Key Facts 9

Intersect ENT Inc., Major Products and Services 10

Intersect ENT Inc. Number of Pipeline Products by Development Stage 11

Intersect ENT Inc. Pipeline Products Summary by Development Stage 12

Intersect ENT Inc. Clinical Trials by Trial Status 13

Intersect ENT Inc. Clinical Trials Summary 13

NOVA-Frontal Indication-Product Status 14

NOVA-Frontal Indication-Product Description 14

NOVA-Frontal Indication-Pivotal Study to Evaluate the NOVA Sinus Implant 15

NOVA- Maxillary Indication-Product Status 16

NOVA- Maxillary Indication-Product Description 16

Propel Implant-Frontal Indication-Product Status 17

Propel Implant-Frontal Indication-Product Description 17

Resolve- Ethmoid Sinus-Product Status 18

Resolve- Ethmoid Sinus-Product Description 18

Steroid-Releasing S8 Sinus Implant-Product Status 19

Steroid-Releasing S8 Sinus Implant-Product Description 19

Steroid-Releasing S8 Sinus Implant-A Clinical Evaluation of the Safety and Efficacy of the Steroid-Releasing S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Sinus Obstruction (RESOLVE II) 20

Intersect ENT Inc., Key Employees 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

OmniGuide, Inc.

Exactech, Inc.

Entellus Medical, Inc.

Intersect ENT Inc., Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand